Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management

Figure 5

Ulcerated colonic mucosa, as viewed by colonoscopy, in a patient experiencing ipilimumab-related colitis.